Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Nostrum Biodiscovery
Nostrum Biodiscovery is a biotech spin-off from the Barcelona Supercomputing Center and the Institute for Research in Biomedicine, specializing in AI-powered molecular design and advanced molecular…
Nostrum Biodiscovery
Nostrum Biodiscovery is a biotech spin-off from the Barcelona Supercomputing Center and the Institute for Research in Biomedicine, specializing in AI-powered molecular design and advanced molecular…
TL;DR
Headquarters: Barcelona, Spain
Founded: 2015
Core offering: AI-powered molecular design and computational drug-discovery services
Proprietary tech: PELE Monte-Carlo molecular modeling and the Nostrum Suite/XNA-Hub
Founders: Modesto Orozco; Víctor Guallar
Company Overview
Problem Domain
Computational drug discovery and molecular design for therapeutics and bio-based chemistry.
Founded
2015
Industry
Biotechnology
Tech Stack
Funding Track Record
Recipient of CDTi/NEOTEC funded projects and public R&D grants; seed capital noted from Fundación Marcelino Botín in company timeline.
781,454 USD
Third‑party profiles list Santander and CDTI among investors and record seed‑stage funding.
Investor Signal
“Received public R&D funding and seed support from CDTi/NEOTEC and listed private investor Santander”